SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-18-000186
Filing Date
2018-01-08
Accepted
2018-01-08 08:40:45
Documents
3
Period of Report
2018-01-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K xene-8k_20180108.htm 8-K 30001
2 EX-99.1 xene-ex991_7.htm EX-99.1 22186
3 GRAPHIC g201801080230287243017.jpg GRAPHIC 5126
  Complete submission text file 0001564590-18-000186.txt   60553
Mailing Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W
Business Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W (604) 484-3300
Xenon Pharmaceuticals Inc. (Filer) CIK: 0001582313 (see all company filings)

IRS No.: 980661854 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36687 | Film No.: 18514983
SIC: 2834 Pharmaceutical Preparations